Legal News

Life Sciences weekly highlights—6 October 2022

Published on: 06 October 2022

Table of contents

  • Manufacture, marketing and sale
  • European Commission Decision Reliance Procedure extended in GB by 12 months
  • DEKRA Certification UK Ltd joins UK Approved Bodies
  • MedTech Europe signs joint industry statement regarding AI Act
  • Parliament adopts measures for stronger response to public health emergencies
  • Research and development
  • Commission updates guidance for clinical trials
  • EMA announces pilot to support developers of advanced therapy medicinal products
  • Post-market
  • MedTech Europe publishes position paper on revision of Product Liability Directive
  • More sections of this document available when you sign-in to Lexis+ or register for a free trial.

Article summary

This week's edition of Life Sciences weekly highlights includes analysis on the National Data Guardian for Health and Social Care’s 2021–22 annual report alongside news that the European Commission Decision Reliance Procedure was extended until 31 December 2023, the European Parliament adopted two legislative proposals to strengthen EU’s response to public health emergencies, MedTech Europe issued a position paper on the proposed revision of Directive 85/374/EEC (the Product Liability Directive) and signed a joint industry statement regarding the Artificial Intelligence Act, and a pilot to support developers of advanced therapy medicinal products was launched by the European Medicines Agency.

Popular documents